This is an old revision of the document!
National Advisory Committee on Immunization
The National Advisory Committee on Immunization (NACI) is a Canadian advisory body operating within the Public Health Agency of Canada (PHAC).1) It is tasked with “providing guidance on the use of vaccines currently or newly approved for use in Canada to the Government of Canada.”2)
History
NACI was formed in 1964.3)
COVID-19
On April 23, 2021, NACI recommended the AstraZeneca-Oxford COVID-19 vaccine be offered to “all Canadians over the age of 30, but only when the benefits outweigh the risks of rare, serious post-vaccine blood clots.”4)
On June 29, 2022, NACI issued guidance recommending “booster doses” of COVID-19 vaccines for all “Canadians at increased risk of serious illness from COVID-19”, regardless of how many doses they had previously received.5)
Organization
Members
1)
Public Health Agency of Canada. (2022, September 16). National Advisory Committee on Immunization (NACI): Terms of reference. Government of Canada. https://web.archive.org/web/20230406185629/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/terms-references.html
2)
, 3)
, 6)
Public Health Agency of Canada. (2022, April 22). National Advisory Committee on Immunization (NACI): Membership and representation. Government of Canada. https://archive.ph/CDZrB
4)
Pelley, L. (2021, April 23). Canadians over 30 should be offered AstraZeneca-Oxford COVID-19 vaccine, advisory body recommends. CBC News. http://archive.today/2021.04.24-073245/https://www.cbc.ca/news/health/astrazeneca-covid-19-vaccine-over-30-naci-1.6000052
5)
Boynton, S. (2022, June 19). COVID-19 boosters recommended this fall ahead of future pandemic wave: NACI. Global News. http://archive.today/2023.04.19-201142/https://globalnews.ca/news/8957899/naci-covid-19-boosters-fall-canada/
7)
Where Are They Now: Nicole Forbes. (2020, November 20). BioCanRx. https://web.archive.org/web/20230316080334/https://biocanrx.com/now-nicole-forbes